drugset / Trial / NCT00410930
Efficacy and Safety of Subcutaneous Immunotherapy in Birch Pollen Allergic Patients
RandomizedParallel-groupDouble-blindTreatment
Summary
To compare versus placebo the efficacy and safety of recombinant Bet v1, natural purified Bet v1 and birch pollen licenced extract used for subcutaneous immunotherapy.
Timeline
- Start
- 2002-11
- Primary completion
- —
- Completion
- 2005-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bet v1 | Protein / enzyme biologic | — | Subcutaneous |